Former Google AI leader lands $100M Series A raise for 'biological software' startup
Jakob Uszkoreit, one of the people who laid the groundwork for generative platforms such as ChatGPT, has secured $100 million in a Series A raise for an AI biotech startup that aims to discover new therapies and vaccines.
Palo Alto-based Inceptive was established in 2021 by CEO Uszkoreit. CBO Kevin Heyries, co-founder and former head of business deveopment at antibody company AbCellera, joined him earlier this year. The fund will support Inceptive’s AI platform that designs mRNA molecules to be licensed to pharma companies for clinical trial investigation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.